gms | German Medical Science

29. Internationaler Kongress der Deutschen Ophthalmochirurgen (DOC)

09.06. - 11.06.2016, Nürnberg

Visual and refractive outcomes of the bioanalogic, polyfocal intraocular lens WIOL-CF after 3 months follow up (P)

Meeting Abstract

Suche in Medline nach

  • Erik Mertens - Medipolis, Ophthalmplogy, Antwerpen, Belgien

29. Internationaler Kongress der Deutschen Ophthalmochirurgen. Nürnberg, 09.-11.06.2016. Düsseldorf: German Medical Science GMS Publishing House; 2016. DocWK 1.24

doi: 10.3205/16doc062, urn:nbn:de:0183-16doc0626

Veröffentlicht: 3. Juni 2016

© 2016 Mertens.
Dieser Artikel ist ein Open-Access-Artikel und steht unter den Lizenzbedingungen der Creative Commons Attribution 4.0 License (Namensnennung). Lizenz-Angaben siehe



Purpose: The purpose of this study was to assess the visual and refractive outcomes of the bioanalogic, polyfocal lens WIOL-CF after 3 months follow up.

Setting: Medipolis-Antwerp Private Clinic, Antwerp, Belgium

Methods: 30 eyes of 15 patients underwent implantation of bioanalogic, polyfocal WIOL-CF lens (MEDICEM Technology s.r.o., Czech Republic). All surgeries were performed by one surgeon using FSLACS procedure. The lens power calculation was based on Haigis formula. Main outcomes measures evaluated during a 3 months follow-up included: binocular and monocular uncorrected visual acuity (UCVA), refraction, best corrected visual acuity (BCVA), distance corrected visual acuity (DCVA) and questionnaire with optical phenomena and spectacle independence evaluations.

Results: The mean monocular logMAR results: UCDVA 0.07±0.09; UCIVA 0.01±0.05; UCNVA 0.06±0.05; BCDVA 0.02±0.04; BCNVA 0.04±0.05; DCNVA 0.06±0.05. The mean sphere –0.25±0.43 D (ranging from –1.50 to 0.00D). The mean binocular logMAR results: UCDVA 0.05±0.05; UCIVA 0.00±0.06; UCNVA 0.06±0.05. No adverse events were found during the follow-up period. All patients were spectacle free. No complaints of excessive halos or glare were reported (only one patient reported mild phenomena).

Conclusions: Bioanalogic, polyfocal IOL implantation after FSLACS was a safe and effective method for pseudophakic presbyopia correction in patients at all distances.